Thailand’s aquaculture remains threatened due to existing and new emerging lethal viral pathogens. Nevertheless, there are no practical and effective methods that have been established to reduce the loss in a critical period. This collaborative work has aimed to develop novel antiviral production platforms in microalgae that can be safely used in shrimp farms.
The green microalga Chlamydomonas reinhardtii is the cell factory of choice for shrimp and fish antiviral biomolecule delivery. The microalga does not produce any endotoxins or infectious agents; thus, it should not raise any health risk or environmental contamination.
The Thai-UK collaborators have developed a simple, low-cost technology for precise engineering of the chloroplast compartment of the algal cell for producing biomolecules. Production of a dried microalgal preparation for shrimp feed supplement is environmentally friendly, using a light-driven cultivation process. Therefore, the use of antiviral microalgae in aquafeed for disease control will establish a new paradigm for shrimp cultivation for future sustainable food production.
Researchers, scholars, and entrepreneurs in aquaculture, feed, livestock, and biopharmaceutical industries are invited to participate in the symposium series on this Current Development of Vaccines and Feed Supplements for Aquaculture (AM) and the High Tech Drugs for Thailand: Biopharmaceutical and Animal Vaccine Production in Thailand and Beyond (PM).
Exclusively for a carefully selected group of potential partners, this event offers participants a unique opportunity to gain knowledge from experts hailing from the UK and Thailand. They will delve into the cutting-edge advancements in the use of antiviral microalgae for disease control in aquaculture in Thailand and beyond. Please note that only short-listed participants will be notified, and we sincerely appreciate your interest in attending the event.
